A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous Garadacimab (CSL312) in Healthy Subjects

• Published in: Journal of allergy and clinical immunology Vol. 147; no. 2; p. AB137
• Main Authors: McKenzie, Andrew, Roberts, Anthony, Malandkar, Sourabh, Feuersenger, Henrike, Panousis, Con, Pawaskar, Dipti
• Format: Journal Article
• Language: English
• Published: St. Louis Elsevier Inc 01.02.2021; Elsevier Limited
• Subjects: Double-blind studies; Intravenous administration; Pharmacokinetics; Placebos